Green Thumb Industries GTBIF
OTC GTBIF
$7.62 +0.37 (+5.10%)
At close: Aug 19, 2026 · 3:59 PM UTC

Green Thumb Industries (GTBIF) Other Non Operating Income (2019 - 2026)

Green Thumb Industries' (GTBIF) quarterly Other Non Operating Income came in at $23.0 million in Q1 2026, up 95795.83% YoY from N/an in Q1 2025, and up 245.85% on a QoQ basis from -$15.7 million in Q4 2025.

Green Thumb Industries (GTBIF) Other Non Operating Income (2019 - 2026) Analysis & Trends

Green Thumb Industries (GTBIF) has 8 years of Other Non Operating Income data on file, last reported at $23.0 million in Q1 2026.

  • Quarterly Other Non Operating Income rose 95795.83% year-over-year to $23.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.3 million (up 526.12% YoY) and the FY2025 annual result came in at $8.4 million, up 191.82% from the prior year.
  • Other Non Operating Income advanced to $23.0 million in Q1 2026, from -$15.7 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $38.1 million in Q3 2025 to a low of -$16.2 million in Q4 2023.
  • A 5-year average of $618529.4 and a median of -$290000.0 in 2024 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2022 — Other Non Operating Income plunged 1296.56% — and 2026, when it jumped 95795.83%.
  • Tracing GTBIF's Other Non Operating Income over 5 years: stood at -$10.4 million in 2022, then sank by 55.55% to -$16.2 million in 2023, then jumped by 41.44% to -$9.5 million in 2024, then tumbled by 65.67% to -$15.7 million in 2025, then surged by 245.85% to $23.0 million in 2026.
  • The last three Other Non Operating Income figures came in at $23.0 million (Q1 2026), -$15.7 million (Q4 2025), and $38.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn
3 Zoetis 31.78 Bn 30.11 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.71 Bn 22.91 Bn 5.10 Bn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn
6 Viatris 18.72 Bn 17.83 Bn 1.46 Bn
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.97 Bn -
10 Green Thumb Industries 1.66 Bn 1.37 Bn 137.87 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.22 Mn
Mar 31, 2026 22.97 Mn
Dec 31, 2025 -15.75 Mn
Sep 30, 2025 38.11 Mn
Jun 30, 2025 -13.99 Mn
Mar 31, 2025 -24,000.00
Dec 31, 2024 -9.51 Mn
Sep 30, 2024 -290,000.00
Jun 30, 2024 2.46 Mn
Mar 31, 2024 -1.76 Mn
Dec 31, 2023 -16.23 Mn
Sep 30, 2023 -631,000.00
Jun 30, 2023 -270,000.00
Mar 31, 2023 924,000.00
Dec 31, 2022 -10.43 Mn
Sep 30, 2022 -2.09 Mn
Jun 30, 2022 5.58 Mn
Mar 31, 2022 11.44 Mn
Dec 31, 2021 872,000.00
Jun 30, 2021 6.83 Mn